Wide Ranks

CLSD

Clearside Biomedical, Inc.

1.07

Top Statistics
Market Cap 81 M Forward PE -2.25 Revenue Growth -91.20 %
Current Ratio 5.07 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -3.86 Enterprise / Revenue 13.15 Price To Sales Trailing12 Months 10.79
Profitability
Profit Margins 0.00 % Operating Margins -8433.33 %
Balance Sheet
Total Cash 29 M Total Cash Per Share 0.3930 Total Debt 47 M
Total Debt To Equity Current Ratio 5.07 Book Value Per Share -0.2530
All Measures
Short Ratio 121.00 % Message Board Id finmb_145617165 Fax 678 270 4033
Shares Short Prior Month 261216 City Alpharetta Uuid ea57bdfa-5d41-3e30-b431-13e72798980d
Previous Close 1.08 First Trade Date Epoch Utc 1 B Book Value -0.2530
Beta 2.33 Total Debt 47 M Volume 182324
Fifty Two Week Low 0.9200 Total Cash Per Share 0.3930 Total Revenue 7 M
Shares Short Previous Month Date 1 B Target Median Price 6.00 Max Age 86400
Recommendation Mean 1.43 Sand P52 Week Change 0.3133 Operating Margins -8433.33 %
Target Mean Price 6.00 Net Income To Common -33456000 Short Percent Of Float 0.0250
Implied Shares Outstanding 76 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 259540 Average Volume10days 259540 Total Cash 29 M
Next Fiscal Year End 1 B Revenue Per Share 0.1120 Held Percent Insiders 0.0739
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.08 Target Low Price 5.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.16 Open 1.08 Free Cashflow -17503250
State GA Dividend Yield 0.00 % Return On Assets -0.4405
Time Zone Short Name EST Trailing Eps -0.4500 Day Low 1.05
Address1 900 North Point Parkway Shares Outstanding 75 M Price Hint 4
Target High Price 8.00 Website https://clearsidebio.com 52 Week Change 0.0594
Average Volume 746514 Forward Eps -0.5000 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 499.80 % Is_sp_500 False
Regular Market Day High 1.10 Profit Margins 0.00 % Fifty Two Week High 2.12
Day High 1.10 Shares Short 1 M Regular Market Open 1.08
Industry Key biotechnology Earnings Growth 0.00 % Enterprise To Revenue 13.15
Revenue Growth -91.20 % Shares Percent Shares Out 0.0235 Operating Cashflow -19111000
Currency USD Time Zone Full Name America/New_York Market Cap 81 M
Is_nasdaq_100 False Zip 30005 Quote Type EQUITY
Industry Biotechnology Long Name Clearside Biomedical, Inc. Regular Market Day Low 1.05
Held Percent Institutions 0.2317 Current Price 1.07 Address2 Suite 200
Enterprise To Ebitda -3.86 Financial Currency USD Current Ratio 5.07
Gross Margins 98.11 % Industry Disp Biotechnology Number Of Analyst Opinions 7
Country United States Float Shares 69 M Two Hundred Day Average 1.25
Enterprise Value 98 M Price To Sales Trailing12 Months 10.79 Forward PE -2.25
Regular Market Volume 182324 Ebitda -25660000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.

It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema.

It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD.

The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences.

Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.